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Abstract  
Societal and personal burden associated with nonadherence to provider prescribed 
antihypertensive regimen challenges both patient and providers to explore methods to improve 
adherence. Nonadherence to antihypertensive therapy severely underscores the efficacy of 
treatment making it a serious issue in population health both from the quality of life and from 
health economics standpoint. In this quasi-experimental study, the effect of 10 minutes of 
structured education on improving adherence to antihypertensive therapy among adults with 
primary uncontrolled hypertension at a rural primary care clinic in Missouri was studied. 
Education was delivered using the SIMPLE method and the study occurred over 6 month period. 
The SIMPLE mnemonic stands for simplifying the treatment regimen,  impartation of knowledge 
through education, modification of patients’ beliefs, provision of open communication, leaving 
biases behind, and evaluating adherence using a valid adherence measurement tools. Level of 
adherence to antihypertensive regimen was measured using the Hill Bone Compliance to High 
Blood Pressure Therapy Scale (HCHTS). Six participants, three Caucasian males and females 
participated in the evidence based project. Pre and post intervention blood pressure values were 
collected and analyzed using paired t test, Wilcoxon signed rank test, and percentages. Thirty 
three percent of the participants experienced a reduction in their Blood Pressure (BP) values and 
met their target BP ranges at 3 and 6 months post intervention. Participants received structured 
education on the importance of adherence and the trajectory of hypertension which will assist 
them in the lifelong self-management of their disease. 
Keyword: antihypertensive, nonadherence, hill bone compliance scale, health belief model 
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Evidence Based Project Proposal  
The diagnosis of hypertension (HTN) requires that patients make life style modifications 
in food, exercise, and adherence to prescribed medications; however, some patients' adherence to 
anti-hypertensive regimen does not meet their provider’s recommendation (Solomon et al., 
2015). Adherence is the degree to which a patient’s behavior such as taking medications, 
following a recommended diet, and modifying lifestyle parallels with the provider’s prescription 
(Rimando, 2013). Patients’ poor adherence to antihypertensive regimen presents challenges to 
successful treatment of hypertension and increases the susceptibility to development of 
preventable complications (Solomon et al., 2015). Nonadherence to medications for management 
of HTN severely underscores the effectiveness of treatment and may contribute to HTN as 
serious population health issue affecting the patients’ quality of life and imposing a national 
economic burden (World Health Organization [WHO], 2003). Therefore, interventions directed 
at improving adherence to hypertension medication would provide a substantial benefit by 
preventing development of complications which include renal failure, blindness, stroke, cardiac 
disease, and death (WHO, 2003).  
Significance and Economic Policy 
  Nonadherence to medication is a worldwide health problem averaging about 50% among 
those with chronic illnesses (WHO, 2003). In the United States, nonadherence to medication 
costs $284 to $634 per year per adult depending on the geographic area and disease condition 
(Nasseh, 2012). In 2010, the direct cost of nonadherence to HTN, diabetes and hyperlipidemia 
medications was $105.8 billion (Nasseh, 2012). In the United States about 59% of patients with 
hypertension are not adherent to treatment regimen (United States Department of Health and 
Human Services [USDHHS], 2015). 
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Local Issue  
Most patients with hypertension who are seen at the project site do not consistently meet 
the Joint National Commission 8 (JNC 8) recommended target range for their blood pressure. No 
standard protocol or avenue exit to further explore the reasons for patients’ noncompliance.  
Additionally, there is a lack of structured hypertension and medication education for patients 
who consistently fail to meet the recommended blood pressure (BP) target at the project site. 
This project was aimed at providing evidence based structured education to increase adherence 
to antihypertensive regimen, and empowering patients to be partners in their care, therefore 
leading to improved patient outcome. 
Diversity 
Harrisonville is a city in Cass county Missouri with a population of 9,983, in 2015 
comprised of 95% Caucasian with less than 1% of African Americans, Hispanics and American 
Indians (United States Census Bureau (USCB), 2014).  About 36.37% of the citizens of 
Harrisonville are religious; in 2015, 6.33% were Catholic; 0.36%, Latter Day Saints, and 3.40% 
claim to be of other Christian faith (City data, 2015). Harrisonville is not ethnically diverse (City 
data, 2015). 
Problem and Policy 
Problem Statement 
Hypertension is a chronic disease which cannot be cured but can be managed by 
following treatment recommendations (Center for Disease Center [CDC], 2014). Poorly 
controlled hypertension predisposes the patient to cardiovascular diseases, stroke, kidney failure, 
and death (CDC, 2014). Adherence to the treatment regimen is important in hypertension 
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management (Mugwano et al., 2016). Nonadherence to hypertensive medication increases a 
patient’s risk of death by up to 80% (USDHHS, 2015). 
Intended Improvement with Purpose  
Interventions directed at improving adherence to antihypertensive medications would 
provide a substantial benefit by preventing development of complications (WHO, 2003).  Poor 
adherence is attributed to lack of adequate knowledge of disease course, complications, and 
medication management; and lack of adherence remains a challenge to the healthcare community 
(Mugwano et al., 2016). Therefore, to overcome the issue of poor adherence, healthcare 
professionals’ need to empower patients with skills through the provision of education so that 
patients are better equipped to manage this chronic deadly condition (Mugwano et al., 2016). 
According to Rimando (2013), patients need education on self-management techniques, 
empowerment, and motivation through continuous support in order to improve adherence to 
HTN regimen. The aim of this project is to empower patients with knowledge through the 
provision of structured evidence based education using the SIMPLE method so they can better 
manage their HTN as they develop self-efficacy. This will foster an increase in adherence, 
achievement of recommended BP target per JNC 8 guideline, and prevention of secondary 
complications of hypertension. 
Facilitators and Barriers 
The main facilitator and support system to the implementation of this project was the 
student investigator’s preceptor at the clinical site and the research evidence that support the 
impact of education on adherence (Hosseininasab et al. 2014; Morgado, Rolo, & Castelo-Branco, 
2011; Roumie et al. 2006; Stewart et al. 2014; Wang et al. 2011). Other facilitators include 
adherence to facilities operating standard including the mission, vision and goals (Khalid, & 
     IMPROVING ADHERENCE TO ANTIHYPERTENSIVE REGIMEN                                 6 
 
Nyvang, 2014). According to Rogers’s innovation theory, people accept change when they are 
partners in the change process (Lee & Shih, 2009). Inclusion of the front line staff in the project 
may have fostered acceptance. Sustainability of the change will be dependent on the positive 
results, feasibility of the project, and constant communication with stakeholders (Rosswurm & 
Larrabee, 1999).  Favorable results provide support and evidence for the incorporation of the 
new practice into standards of care with support from stakeholders. 
Some of the foreseen barriers to implementation of the project included patients’ 
unwillingness to participate in the evidence based practice (EBP) projects. However, patients 
were provided with information to ensure informed decision making. Another barrier was 
inadequate time to conduct patient education in the outpatient setting because patient 
consultation time with the provider is tightly managed. The brief office visit posed a major 
obstacle in achieving the 10 minutes structured educational session. Another barrier that may 
inhibit sustainability of the project could be failure of stakeholders to appoint a project 
coordinator who will monitor compliance and sustainability after completion of the project. 
Review of the Evidence 
PICOT 
In adults with primary hypertension does providing a 10 minute structured education 
session using the SIMPLE method improve adherence to antihypertensive regimen and 
achievement of blood pressure target range per JNC 8 guideline within 6 months in a rural 
primary care clinic in Missouri. 
Search Strategies 
To identify evidence to address the inquiry, a PubMed search for studies published from 
2005 to 2016 using the search words, role of education, adherence, and antihypertensive regimen 
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yielded 40 publications. Eight out of the 40 were clinical trials, seven were systematic reviews, 
and two were cohort studies. The remainders of the publication were 15 qualitative studies, five 
integrative reviews and two case studies. Search of the Cochrane Library for studies published 
from 2005 to 2016 using the key words adherence, antihypertensive,  medication and patient 
education yielded 75 results, of which 68 were clinical trials, four were  integrative reviews, one 
was a  systematic review and two were cost effectiveness analysis studies. A search of the 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) for studies published from 
2006 to 2016 using the search words of medication adherence, antihypertensive, and patient 
education yielded 83 results. For direct evidence application to this project, only twenty of the 
studies were included which were three systematic reviews (level l evidence), 16 randomized 
clinical trial (level l l), and one cohort study (level 1V). In addition, other credible organizations 
and government websites such as the CDC, WHO, USDHHS were assessed and relevant 
information was used. 
Evidence  
Education and Support 
According to the Million Heart Program ® (2013), effective hypertensive therapy 
prescribed by a competent and knowledgeable provider to control hypertension will only work if 
taken as prescribed by the patient; therefore, patients need education and motivation to 
continuously be adherent to prescribed treatment. The review of evidence did support that 
providing intervention in the form of patient education has the prospect of improving adherence 
to antihypertensive medication (Hosseininasab et al. 2014; Morgado, Rolo, & Castelo-Branco, 
2011; Roumie et al. 2006; Stewart et al. 2014; Wang et al. 2011), see Appendix A for 
synthesizes of evidence. However some of the studies did show that multifactorial interventions 
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were superior in improving adherence to medication and lowering overall BP in patients with 
hypertension compared to education alone (Bosworth et al., 2009; Cheema, Sutcliffe, & Singer, 
2014; Pladevall et al.,; 2010 Pouchain et al., 2013). Healthcare providers have the distinctive and 
essential role of providing patients with the tools they need to be partners in their health care 
(American College of Preventive Medicine [ACPM], 2011).  Many of the studies showed that 
patients who are equipped with knowledge of the hypertension trajectory, usefulness of 
medication, and who were closely followed up were more empowered and participatory in their 
care (Saleem et al., 2015).  Also, these patients were more adherent to their treatment regimen 
and achieved their provider recommended blood pressure target (Roumie et al., 2006; Saleem et 
al., 2015). 
Adherence to medication entails that patients believe there is a substantial benefit to the 
medicine being prescribed and accept responsibility to adhere to provider recommended 
instructions (ACPM, 2011),  Studies have shown that providers who use a multidimensional 
approach to medication adherence, which includes improved patient and provider 
communication and relationship, help their patients achieve high level of adherence (WHO, 
2003). Although trust building is a skill that takes time to develop and successful two way open 
patient communications may be time consuming in a primary care setting, investing in both has a 
substantial gain for the patient and provider in improving adherence to medications (ACPM, 
2011). Continuous progress is achieved when patients have both trust and positive experience 
with the healthcare professionals and with the care outcome (USDHHS, Million Heart Program 
® 2013). 
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Lifestyle Modification 
Education on medication adherence and life style modification increases adherence to 
hypertensive regimen (Golshahi, Ahmadzadeh, Sadeghi, Mohammadabad, & Pourmoghaddas, 
2015). In a randomized control trial, study participants in the intervention group who received 
education on life style modification and importance of medication adherence had a significant 
reduction in systolic blood pressure (SBP, p = 0.004) and a significant reduction in diastolic 
blood pressure (DBP, p = 0.001) because of increased adherence to medication and changes in 
lifestyle in areas of diet and exercise (Golshahi et al., 2015). Although the researchers collected 
information on hypertension knowledge and drug adherence through direct interviewing of 
participants and without the use of a valid adherence tool, the strength of this study lies in the 
high number of 180 participants and length of study time (Golshahi et al., 2015). 
Culturally Tailored Education 
Culture and ethnicity are among the factors that influence adherence to high blood 
pressure management regimen (WHO, 2003), and incorporating culturally tailored hypertension  
education management is of equal importance in assisting patients from diverse cultural 
background and ethnicity to acquire knowledge and manage their condition (WHO, 2003). 
Holmes et al. (2012) found that African Americans followed by Hispanic have the lowest odds of 
adherence to hypertension regimen compared to Caucasians. Therefore, culturally tailored 
educational interventions have been found to improve adherence to hypertension medication 
among persons with HTN who are of African descent (Beune et al., 2014; Meinema et al., 2015). 
In management of hypertension, patients are their main caregivers while the health care 
providers have the essential role of teaching and supporting patients in self-management of their 
disease condition (Beune et al., 2014). Health care professional need to understand how patients’ 
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beliefs about hypertension affect health behavior and the cultural barriers faced by patients as 
they struggle with BP control and adherence to therapy (Beune et al., 2014). Addressing these 
barriers through a culturally tailored education has the prospect of improving adherence to 
treatment and leading to better BP control (Beune et al., 2014).  
Multidimensional Intervention 
According to WHO (2003), the causes of nonadherence to antihypertensive are 
multifactorial and include age, gender, ethnicity, socioeconomic status, severity of illness, 
number of daily medications, and lack of knowledge of usefulness of medication and 
comorbidities. The first important initiative in addressing nonadherence is the establishment of 
collaboration between health care practitioners and patients with the ultimate goal of increasing 
adherence and achieving the best health outcomes for the patients (ACPM, 2011). Cheema, 
Sutcliffe, and Singer (2014) conducted a systematic review and meta-analysis of randomized 
controlled trial that studied the influence of pharmacy led interventions on blood pressure control 
in patients with hypertension. The analysis found that the pharmacist led educational 
interventions for patients with hypertension was associated with significant reductions of 6.1 
mmHg in SBP in 11 studies that involved 2,240 patients (p < 0.00001, Cl 95%) and 2.5 mmHg 
reduction in DBP in studies that involved 2,246 patients (p < 0.00001, Cl 95%). According to the 
researchers, patients’ education alone was unsuccessful in improving adherence in certain 
situations, but addressing each patient’s unique challenge and barriers to adherence was superior 
to education alone in improving adherence. 
Evidence Based Tool, the SIMPLE method  
The SIMPLE method (see Appendix B for the SIMPLE tool) was developed by Atreja, 
Bellam and Levy in 2005. The mnemonic stands for Simplifying the treatment regimen, 
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knowledge Impartation through education, Modification of patients’ beliefs, building trust 
through the Provision of open communication, doing away with bias by Leaving it behind, and 
Evaluating adherence using a valid adherence measurement tools.  The SIMPLE method offers 
Health care providers the tool to base and modify their intervention in order to enhance patients’ 
adherence to high blood pressure treatment regimen (Atreja et al., 2005). Improving medication 
adherence can be viewed by those not affected as a simple task, but for the patients affected, this 
is a complex task with many competing life factors (ACPM, 2011). Studies have shown that the 
SIMPLE interventions which encompasses a multifactorial approach are the most effective in 
fostering medication adherence (Atreja et al., 2005).  
According to USDHHS Million Heart Program ® (2013), a multifactorial intervention is 
more effective than any single intervention in increasing adherence to a high blood pressure 
treatment regimen The use of the SIMPLE tool by pharmacists and nurses in face-to-face settings 
has been shown to be effective in improving adherence as it addresses causes of nonadherence 
(ACPM, 2011). The effectiveness of the SIMPLE tool can be enhanced by the use of valid data 
to measure adherence on a regular bases, and in some cases, mere simplification of medication 
regimen was effective in improving adherence (USDHHS, Million Hearts Program ®, 2013). 
The Health Belief Model 
The Health Belief Model (HBM) was developed in the 1950s by the United States Public 
Health Services (Jones et al., 2014). Although the primary focus of HBM was on health 
promotion, it is applicable in varied health related behaviors (Jones et al., 2014) and will be used 
as a theoretical framework for improving adherence in this project. Because the causes of 
nonadherence to prescribed antihypertensive are linked to patients behaviors (WHO, 2013),  
behavioral model such as the HBM offers healthcare professional a deeper understanding of the 
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correlation between patients’ beliefs and nonadherence to prescribed regimen (Aki et al., 2014). 
The effectiveness of HBM in predicting and describing health care related behavior was well 
documented in two meta-analyses (Carpenter, 2010; Harrison, Mullen, & Green, 1992). Both 
meta-analyses concluded that perceived barriers and benefits are the constructs of HBM with the 
prospect of predicting health related behavior. According to the HBM, an individual's choice of 
health related action is dependent on perceived benefit of the action and barriers (Finfgeld et al., 
2003). The Health Belief Model originally had four constructs: perceived susceptibility, 
perceived severity, perceived barrier, and perceived benefit (Jones et al., 2014). Two constructs, 
cue to action and self-efficacy were later added in the 1980’s as the model evolved (Jones et al., 
2014). The Health Belief Model is easy to implement; however, the major limitation to the use of 
this model is that it presumes the acceptance of a particular set of values and it is time bound 
(Finfgeld et al., 2003).  Additionally, the model does not consider the influential role emotions 
has on healthcare related behavior (Finfgeld et al., 2003).  
Methods 
Institutional Review Board (IRB) and Site Approval 
The Primary IRB for this project was University of Missouri Kansas City. The minimal 
risk of harm with this project was the breach of confidentiality. Approval to conduct the project 
at the project site was obtained from the student investigators preceptor. 
Funding  
The cost for implementing and disseminating this project was $450 and included in the 
total cost were supplies, materials, printing, copying and transportation to conference for 
dissemination (see Appendix C for cost of project). The student investigator obtained funding 
from the University of Missouri Graduate Women Council fund. 
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Ethical Issues  
The advocacy role of the student investigator included the safeguarding of patient 
autonomy, which prioritizes voluntary choice without coercion or fear of retribution, and 
provision of information needed to make informed choice or consent (Ridley, 2009). To protect 
patient’s privacy while also maintaining confidentiality, data collected and reported was de-
identified and there was no research conflict of interest.  
Setting and Participants 
The setting for the project was an outpatient primary care clinic in rural Missouri. 
Inclusion criteria were adults with diagnosis of primary hypertension with uncontrolled 
hypertension and who consistently over the clinic visits did not meet the target BP as stipulated 
by the JNC 8 guideline. Exclusion criteria included patients with controlled hypertension and 
those with hypertension not classified as primary. After initial entry into the study, an adherence 
measurement tool was administered and the patients with scores indicating nonadherence to the 
recommended hypertension regimen continued in the study. The estimated sample size was 30 to 
40 (see Appendix D for Logic Model). 
Evidence Based Practice Intervention 
The SIMPLE method is the most effective in fostering medication adherence (Atreja et 
al., 2005).  The SIMPLE tool was utilized in the administration of individualized education to 
participants. Education was tailored to patients needs based on response on adherence 
measurement tool.  
Recruitment of participants commenced during the last week of August 2016, (see 
Appendix E, for recruitment script). The student investigator recruited potential participants 
during clinic appointments and provided participants with information on the project (see 
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Appendix F for Intervention flow diagram). The student investigator coded the participants and 
obtained data of BP from the electronic medical record. Each participants then completed the 
HCHTS which the student investigator used to address adherence and BP was measured. 
Participants whose responses to the HCHTS indicated nonadherence continued in the study and 
received 10 minutes of structured education using the SIMPLE method. The education was 
provided by student investigator during the current clinic appointment. Upon return to the clinic, 
adherence to antihypertensive regimen and BP were measured by the student investigator at 
intervals of 3 and 6 months. The de-identified data was entered into an electronic spreadsheet 
and then into a secured database REDCap. After placement into REDCap, the electronic 
spreadsheet was destroyed (see Appendix G for project time flow). 
Rosswurm and Larrabee Evidence Based Practice Model Change 
Rosswurm and Larrabee’s evidence based practice model developed in 1999 was chosen 
to guide the evidence based process of this project. The model has six stages which are (1) assess 
the need for change, (2) link problem with interventions and outcomes, (3) synthesize best 
evidence, (4) design practice change (5) implement and evaluate change in practice, and (6) 
integrate and maintain practice change (Rosswurm & Larrabee, 1999). The model content is 
applicable and suitable for EBP change in outpatient settings (Pipe, 2007). 
Change Model 
The change model chosen to guide the implementation of this project was the Precaution 
Adoption Process Model (PAPM) developed by Weinstein in 1988. The PAPM conceptualizes 
behavior as dynamic process based on stages of change (Minchew, 2015). The model has seven 
stages of change (see Appendix H for PAPM model): (1) lack of awareness, (2) awareness stage, 
(3) deliberation on taking action, (4) the individual may decide not to act, (5) decides to act, (6) 
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actual, and (7) maintenance (USDHHS, 2005). The PAPM calls on practitioners to develop 
intervention strategies that take into account the stages that pave the way for active decision-
making (USDHHS, 2005).  
Study Design  
The study was a quasi-experimental quality improvement project, specifically interrupted 
time-series with pre and post intervention with one cohort. Interrupted time-series design has the 
advantage of multiple measurements of both the pre and post intervention making it easier to 
address and control for confounding variable (Harris et al., 2006). The aim of this quasi 
experimental project was to demonstrate causality between SIMPLE intervention and adherence 
to antihypertensive treatment regimen and controlled BP. The pre-intervention measurements for 
the project included measuring medication adherence using HCHTS and previous clinic BP 
readings. The post-intervention measurements included measuring adherence and BP at 3 and 6 
months. 
Validity 
The use of a valid adherence measurement tool HCHTS (Kim, Hill, Bone, & Levine, 
2000), structured education using the SIMPLE method, and the use of multidimensional 
approach (Bosworth et al., 2009; Cheema, Sutcliffe, & Singer, 2014; Pladevall et al., 2010; 
Pouchain et al., 2013) increased the internal validity of this project. Threats to external validity 
included low participant number, participants’ unwillingness to complete study, and participants 
continued nonadherence to treatment regimen even after receiving structured education. Another 
threat to validity was the inability to appropriately control confounding variables due to the lack 
of randomization; however, this was overcome with interrupted time-series design, although 
recruitment of a sample size reflecting a power of .8 with medium effect and alpha .05 was not 
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achieved in the project. In the project proposal, the anticipated sample size and homogeneity of 
the sample strengthened the external validity for transferability of the study results and 
intervention to like settings (Harris et al., 2006). 
Outcomes of Measure 
The primary outcome measure was improved adherence to antihypertensive regimen 
based on participants’ responses on the HCHTS, and the secondary outcome measure was the 
post intervention mean BP values that meet the target range per JNC 8 guidelines and the 
measure of change from pre to post values. Because the target BP values vary for different 
individuals based on age and comorbidities, target BP for individuals was determined based on 
JNC 8. 
Measurement Instruments 
Level of adherence to antihypertensive regimen was measured using the HCHTS (see 
Appendix I for measurement tool) while blood pressure will be measured using the clinic Blood 
pressure monitor, the Welch Allyn® monitor. The Hill Bone compliance to high blood pressure 
treatment scale is composed of  14 items with a Likert four point response; (4) all the time, (3) 
most of time, (2) some of time, and (1) never.  The total score ranges from a minimum of 14 to a 
maximum of 56 (Kim et al., 2000). The sodium subscale contains three items which assesses 
intake of salty foods, keeping appointment subscale contains three items which assesses 
appointments for provider visits and prescription refills, and the medication taking subscale 
contains eight items which assesses medication taking behavior (Kim et al., 2000). 
The validity of HCHTS has been addressed by researchers and the tool was found to be 
valid.  Kim et al. (2000) assessed the suitability and validity of the HCHTS with focus on low 
literacy and cultural sensitivity among hypertensive adult patients in the community care setting 
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enrolled in hypertension care and controlled clinical trials. The reviewers found that the alphas 
for the total scale were 0.74 and 0.84, and the average inter item correlations of the 14 items 
were 0.18 and 0.28. In a review by Lavsa, Holzworth, & Ansani, (2011), the researchers assessed 
the validity and internal consistency of the HCHTS among adult hypertensive patients attending 
a community internal medicine clinic, and the reviewers reported an internal consistency 
reliability alpha of 0.68. However, there were some limitations to the use of the scale and 
generalization across diverse patient population made the scale only relevant in cardiovascular 
conditions (Lavsa et al., 2011). 
The WelchAllyn Vital Signs monitor is a non-invasive blood pressure monitor that 
utilizes the oscillometric technology to measure blood pressure and is widely used in hospitals 
and outpatient settings because of the accuracy of the monitor, and pulse and temperature are 
also measured (Jones, Taylor, Poston, & Shennan, 2001). In order to test the validity of the 
WelchAllyn Vital sign monitor, Jones et al. (2001) conducted a study comparing the BP readings 
from the WelchAllyn reading with that of mercury sphygmomanometer. The study results 
showed the Welch Allyn monitor to be precise in measurement both for systolic and diastolic 
blood pressure over a wide range of readings in the adult population. The monitor achieved a 
grade A rating (highest grade) at most levels and was recommended for use in clinical setting 
(Jones et al., 2001). 
Quality of Data 
The estimated number of participants for the study was 30 to 40 adults with uncontrolled 
hypertension due to nonadherence to treatment regimen. The estimated sample size was not met, 
seven participants were recruited and six completed the study. To further promote the quality of 
data, the pre and post intervention BP values were compared and analyzed. Results from 
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systematic reviews (Cheema, 2014; Gwadry-Sridhar, 2013; Viswanathan, 2012) were used as the 
benchmark for the quality of the data (see Appendix J for data collection template). 
Analysis Plan 
 The statistical analyses used to draw inference from the data in this quasi experimental 
project were independent paired t-tests and Wilcoxon signed rank test (see Appendix K for 
definition of terms). The pre and post intervention BP values, were compared for change within 
the cohort. The significance level was .05.  Frequencies and percentages were determined for 
post-only BP that achieved the target BP range (see Appendix L for statistical analysis template). 
Results 
Setting and Participants 
The quasi experimental evidence based quality improvement project was completed at an 
outpatient primary care clinic in rural Missouri. Participants were recruited between August 2016 
and September 2016. A total of seven participants with uncontrolled primary hypertension were 
recruited for the study: however, only six of the participants completed the study, one of the 
participants was unable to keep the scheduled 3 and 6 month appointments, as such was excluded 
from the study and data analysis. The mean age of the participants was 62.1 years. The oldest 
participant was 79 years while the youngest was 35 years old. All study participants were 
Caucasians.  
Intervention Course 
Potential participants were identified through prospective chart review and recruitment 
occurred during individual participant’s clinic appointments. After recruitment into the study, 
each participants BP was obtained and the HCHTS measurement tool was administered and the 
responses to the HCHTS were reviewed with each participant. Each participant’s educational 
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level was obtained. The education was delivered using the SIMPLE method and participants 
were given take home pamphlets. Participants’ questions were answered and participants were 
scheduled for a 3 and 6 months follow up appointment. At the 3 and 6 month follow up visit, BP 
readings were obtained and compared to pre-intervention BP values and reviewed with the 
participant. Participants received education based on responses on the adherence tool. 
Outcome Data by Sub-Topics 
Three months post intervention data. Although the t test did not show statistical 
significance at p < 0.05 however, thirty three percent of the participants had a reduction in both 
their SBP and DBP at 3 months met their target SBP and DBP ranges. The Wilcox signed rank 
test showed a zero median difference between pre intervention SBP and 3 months post 
intervention SBP likewise the median difference between the pre intervention DBP and 3 months 
post intervention DBP was zero. That data showed that education can lead to reduction in BP 
values (See Appendix P). 
Six months post intervention data. The t test result for the 6 months data did not show 
statistically significant difference at p < 0.05 however, thirty three percent of the participants met 
their target SBP and DBP ranges at the 6 months follow up visit. The Wilcoxon signed rank test 
at 6 months post intervention showed a zero median difference between pre intervention SBP 
and 6 months post intervention SBP. Likewise the median difference between the pre 
intervention DBP and 6 months post intervention DBP was zero. That data showed that 
education can lead to a reduction in BP values (See Appendix Q). 
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Discussion 
Successes, Most Important  
Thirty-three percent of the participants met their target BP ranges at 3 and 6 months post 
intervention. The participants were equipped with knowledge of hypertension trajectory, 
medication management, and the importance of adhering to prescribed treatment regimen. 
Hopefully the knowledge acquired by the patients will be utilized in the future. According to 
Faller, Ehlebracht-König, and Reusch, (2015), health education provides patients with the skills 
they need to self-manage their illness and is the bedrock for behavior modification that 
ultimately leads to better outcome; therefore patient education must be a continuous process and 
health care providers must not relent in this aspect of care giving. The authors also believed that 
health education empowers patient to make informed decisions and be partners in their health 
care.  
Study Strengths  
The study strength includes the ease of accessibility to the resources needed to complete 
project, the support of the preceptor, and the ease of recruitment of participants. The recruitment 
and implementation of the intervention was without obstacle as it occurred at the same clinical 
site and during patients scheduled clinic appointments. Patient did not have to make extra visits 
to the clinic.  
Results Compared to Evidence in the Literature  
The results of the study failed to mirror the evidence from literature that provided the 
evidence support for the project. In a randomized control trial, study participants in the 
intervention group who received education on life style modification and medication adherence 
had a significant reduction in systolic blood pressure (SBP, p = 0.004) and a significant reduction 
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in diastolic blood pressure (DBP, p = 0.001). This was due to increased adherence to medication 
and lifestyle modification (Golshahi et al., 2015). However, the results of this project did not 
show any statistical difference between the pre and post intervention systolic and diastolic BP for 
67% of the participants largely due to small sample size and short length of study. 
According to the USDHHS Million Heart Program ® (2013), multifactorial interventions 
were shown to be more effective than any single intervention in increasing adherence to a high 
blood pressure treatment regimen in multiple studies. Therefore, the use of the SIMPLE tool by 
pharmacists and nurses in face-to-face settings was shown to be effective in improving 
adherence as it addressed causes of nonadherence in (ACPM, 2011). Although the SIMPLE tool 
was the intervention tool in this current study the outcome data did not demonstrate a positive 
outcome for the majority of participants as demonstrated in literature.  
A systematic review of pharmacy led interventions on blood pressure control in patients 
with hypertension by Cheema, Sutcliffe, and Singer (2014)  showed significant reductions of 6.1 
mmHg in SBP in 11 studies that involved 2,240 patients (p < 0.00001, Cl 95%) and 2.5 mmHg 
reduction in DBP in studies that involved 2,246 patients (p < 0.00001, Cl 95%). In contrast, the 
results of this current project did not demonstrate reductions in BP values post intervention for 
67% of the participants.  
Limitations 
Internal Validity    
According to Vogt (1993) confounding variables shadow the effects of another variable 
and therefore obscure both the data and conclusions drawn from the study. The effects of 
confounding variables in a study make it difficult to ascertain whether the interventions caused 
the effect or that the outcome was due to the influence of confounding variable (Vogt, 1993). 
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Confounding variables may inaccurately increase or decrease the degree of an association, or 
even invert the direction of the association between the intervention and outcome in a study 
(Kamangar, 2012). For this EBP project, some of the sources of confounding variables included 
activities the patient may have engaged in prior to appointment and shortly before the BP check. 
The consumption of caffeine, smoking, or alcohol 30 minutes before measuring BP elevates the 
values (CDC, 2014). Another confounding factor of concern is if the patients took their 
antihypertensive medication before appointment or if it was skipped, as this will have an effect 
on the BP value.  
For a variable to be confounding, it must be aligned with an independent variable and 
also be directly allied with the study outcome and dependent variable (Vogt, 1993). In order to 
make a study outcome valid, the effect of confounding variables must be controlled.  Effects of 
confounding variables must be overcome in order to improve the validity of the outcome of 
research study, and randomization with large sample sizes has been shown to be one of the most 
effective method to decrease the effect of confounders because randomization has the potential 
of balancing the different aspects of the study for both the unknown and known confounding 
variables (Kamangar, 2012). However due to the small sample size and short time length, 
randomization could not be used in the current study.  
External Validity  
This evidence-based project had a small participant size of six Caucasian adults. The 
mean age of the participants was 62.1 years. The oldest participant was 79 years while the 
youngest was 35 years old. The small sample size and lack of diversity in race, ethnicity, and age 
affects the external validity of the findings. For any evidence-based program to be acceptable, 
the issue of external validity must be addressed (Prohaska & Etkin, 2010). However the project 
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can be replicated to test the validity, and according to Prohaska and Etkin, (2010) the factors 
which determine the acceptance of an evidence-based program is the establishment of success of 
the program through numerous replications of the intervention within diverse groups and 
settings.  
Sustainability of Effects and Plans to Maintain Effects  
Sustainability of the project will be dependent on the appointment of a project 
coordinator who will monitor compliance and sustainability of the project. Second, measurement 
of adherence and patient education can be incorporated into the care of patients with 
uncontrolled hypertension due to nonadherence by allocating 5-10 minutes of their clinic 
appointment to education.  
Efforts to Minimize the Study Limitations  
The major limitation to this EBP project was the small size and lack of diversity of 
participant in terms of race, ethnicity, and age. To minimize this in a future study, the study 
should be replicated in a setting with diverse population, and conducted over a longer period of 
time. 
Interpretation 
Expected and Actual Outcomes  
The expected outcome was that participants would achieve their target blood pressure 
range as evidenced by reduction in 3 and 6 months post intervention BP readings However, 
33.3% of the participant achieved their target BP ranges. The failure of the other 67% to achieve 
the expected outcome is attributed to the short length of project implementation. If the project 
was completed over a longer period of time, then BP control may have been fostered and found 
in longer term outcome measures. A longer duration of interaction with the participants may 
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have improved the therapeutic relationship and communication line between the student 
investigator and the participants. 
Intervention Effectiveness  
The ease and effectiveness of the interventions are attributed first to all the participants 
who were cooperative and willing to participate in the project, and second to the support of the 
project preceptor who allocated time for the student investigator to offer the health education to 
the participants. And last, the organizational structure was welcoming to programs that have the 
potentials of improving patient care outcomes. 
Intervention Revision  
Telephonic follow up care might improve attainment of the outcomes of the project. 
According to Adams et al., (2013), telephonic health training is positively associated with patient 
motivation. Telephonic follow up care has been used to improve patient care in other chronic 
disease care. In a study conducted by Slater and Philip (2008) on cost effectiveness of telephonic 
care, the researchers found that a telephonic program for Congestive heart failure was effective 
in meeting both patient and organizational goals in reducing readmissions. According to Martin, 
French, and Janos (2010), once the therapeutic relationship was established, patients became 
more open during telephonic care in acknowledging symptoms, asking health related questions 
and  in accepting and working towards prescribed treatment regimen in order to achieve their 
health goal. 
Expected and Actual Impact to Health System, Costs, and Policy  
The aim of this project was to empower patients with knowledge through the provision of 
structured evidence based education using the SIMPLE method so they can better manage their 
HTN as they develop self-efficacy. This would lead to an increase in adherence, achievement of 
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recommended BP target per JNC 8 guideline and prevention of secondary complications of 
hypertension. The estimated cost of project intervention was $650 while the actual cost of project 
intervention was $450. Included in the cost of the project intervention were the cost of supplies, 
printing, copying, and dissemination. This project should be embarked on as a continuous quality 
improvement and does not require major organizational policy changes. The completion of this 
project was made possible by funding from presidents and past presidents general assembly of 
greater Kansas City's memorial fund to the Mary Margaret Miller graduate assistance 
endowment fund award through the University of Missouri Kansas City Women’s Council 
Graduate Assistance Fund 
Conclusions 
Practical Usefulness of Intervention 
 The implementation of this evidence based intervention will enhance the quality of care 
for patients with hypertension through standardization of education and measurement of 
adherence. Furthermore the intervention will empower patients to be partners in their own care, 
and improve communication between patient and healthcare professionals leading to reduction in 
health care burden and improved quality of life. 
Further Study or Implementation of Intervention  
 The applicability of this evidence based intervention on other chronic condition should be 
studied. This intervention may also be beneficial to patients with other chronic cardiovascular 
diseases who are not adherent to prescribed treatment regimen.   
Dissemination  
The proposal for this evidence based quality improvement project was disseminated at 
the University of Missouri Kansas City Health Science Student Summit in spring 2016 and the 
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Advanced Practice Nurses of Ozark, Cradle to Grave Conference on November, 11, 2016. The 
final project was accepted for presentation at the University of Missouri Health Science Summit 
on the 25th of April 2017. Dissemination of the EBP project findings will promote professionals 
to adopt this evidence based practice intervention into their practice settings in order to improve 
the management of patients with uncontrolled hypertension due to nonadherence.  
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Appendix A 
Synthesis of Evidence Table 
Education and Support 
First Author Year 
Title/Purpose 
Research 
design 
Evidence 
level 
Sample 
Setting 
Results 
Analysis uses 
Limitation and or 
Usefulness 
Gwadry-Sridhar (2013). Impact 
of interventions on medication 
adherence and blood pressure 
control in patients with essential 
hypertension: a systematic review 
by the ISPOR medication 
adherence and persistence special 
interest group.  
Systematic 
review 
 Level I 
 
 97 articles 
published 
between 
1979 and 
2009  were 
retrieved and 
reviewed 
35 (35 of 97, 36.1%) 
examined 
interventions to 
directly improve 
medication 
adherence, and (58 of 
97, 59.8%) were 
randomized 
controlled trials.  
The systematic review 
showed that improving 
patients’ knowledge of 
medication has the 
prospective of improving 
adherence to 
antihypertensive and 
improving clinical 
outcome. 
Alhalaiqa (2012). Adherence 
therapy for medication non-
compliant patients with 
hypertension: A randomized 
controlled trial.  
Randomized 
Controlled 
Trial 
Level I 
136 non-
compliant 
hypertensive 
patients, 130 
completed.  
Conducted in 
an outpatient 
settings 
Intervention group 
achieved a decrease 
in SBP by mean of 
−23.11 mm Hg (95% 
CI) and diastolic BP 
(DBP) by 
−15.18 mm Hg (95% 
CI) 
Analysis CI 
Adherence scores were 
correlated with BP (SBP: 
−0.71, P<0.001, DBP: 
−0.63, P<0.001) 
negatively, that is, 
reduction in BP was the 
outcome of adherence.   
Viswanathan (2012). 
Interventions to Improve 
Adherence to Self-administered 
Medications for Chronic Diseases 
in the United States: A 
Systematic Review.  
Systematic 
review  
Level I 
4124 eligible 
peer-
reviewed 
publications 
and abstracts 
from 
MEDLINE 
and the 
Cochrane 
Library 
published up 
unto 4 June 
2012 
Reduction of 
copayments, case 
management and 
patient level 
education all 
improves adherence 
to antihypertensive 
therapy in diverse 
clinical conditions 
Evidence is lacking on the 
broad applicability of 
these approaches and 
long-term health outcome 
Hosseininasab (2014). Self-
Monitoring of Blood Pressure for 
Improving Adherence to 
Antihypertensive Medicines and 
Blood Pressure Control:  
Randomized 
Controlled 
Trial. Level 
II 
190 study 
hypertensive 
subjects in an 
outpatient 
setting 
Intervention group 
achieved a reduction 
in DBP up to week 
24 (P = 0.01). Both 
groups showed 
Education and self-
monitoring of BP leads to 
better adherence to BP 
medication 
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adherence rates of 
more than 95% 
Analysis CI 
Hacihasanoğlu (2011). The effect 
of patient education and home 
monitoring on medication 
compliance, hypertension 
management, healthy lifestyle 
behaviors and BMI in a primary 
health care setting.  
Randomized 
control 
study 
Level II 
120 
hypertensive 
patients 
monitored at 
home 
The number of 
patients who 
regularly use 
medication was 
signiﬁcantly 
increased after 
education (p < 
0.001); there was no 
significant increase in 
medication 
compliance in the 
control group (p > 
0.05) 
Intervention in form of 
education improved 
medication adherence 
Saleem (2015), Pharmacist 
intervention in improving 
hypertension-related knowledge, 
treatment medication adherence 
and health-related quality of life: 
a non-clinical randomized 
controlled trial.  
Randomized 
control trial 
Level II 
385 
hypertensive 
patients aged 
18 years and 
above. Study 
was 
conducted in 
an out-
patient 
cardiac 
setting 
The intervention 
group had a 
significant increase 
(P < 0.001) in their 
knowledge of 
hypertension and 
increase in 
medication adherence 
on the HFQ and DAI-
10 tools respectively.  
Analysis- CI 
 A pharmacist-initiated 
educational interventions 
helped improving 
knowledge of 
hypertension and 
adherence to medication 
regimen. 
Narjis (2013). Impact of a 
community pharmacists' 
hypertension-care service on 
medication adherence.  
 
Randomized 
Control 
Study 
Level II 
176 patients 
with 
hypertension 
in a 
community 
setting 
The intervention 
group had a higher 
odds of adherence to 
antihypertensive drug 
therapy in was 4.07 
(95% CI: 1.04-15.95; 
P = .044) times more 
than the control 
group. 
Analysis- Odds ratio 
and CI 
Education improved 
adherence to 
antihypertensive therapy 
Wang (2011). Effects of 
pharmaceutical care interventions 
on blood pressure and medication 
adherence of patients with 
primary hypertension in China.  
Randomized 
control trial 
Level II 
60 
hypertensive 
patients in 
out-patient 
setting  
The intervention 
group showed a 
higher percentage of 
patients with high 
adherence (72.41%) 
at 12 months, 
compared to the 
control group 
Pharmaceutical care 
intervention might 
contribute to better BP, 
and could improve 
medication adherence 
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Morgado (2011). Pharmacist 
intervention program to enhance 
hypertension control: A 
randomized controlled trial.  
Randomized 
control trial 
Level II 
197 
hypertensive 
patients 
The intervention 
group had higher BP 
control (P = 0.005). 
SBP was significantly 
lower (-6.8 mmHg, P 
= 0.006) and DBP (-
2.9 mmHg, P = 
0.020).Adherence 
level was also higher 
in the intervention 
group compared to 
the control group 
(74.5% vs. 57.6%, P 
= 0.012). 
Analysis- CI 
Pharmacist intervention in 
form of education has the 
prospect of improving 
adherence to 
antihypertensive therapy 
Roumie (2006). Improving blood 
pressure control through provider 
education, provider alerts, and 
patient education: a cluster 
randomized trial. 
Cluster 
randomized 
trial 
Level II 
1341 
veterans and 
182 
Providers in 
an out-
patient 
settings 
Patients in the patient 
education group 
achieved a decrease 
in their  SBP  
compared with those 
in the provider 
education or provider 
education and alert 
groups 95% CI, 1.06 
to 1.62]; P = 0.012). 
Analysis- CI 
Patient education in 
addition to provider 
education can lead to 
improvement in adherence  
Stewart (2014). A multifaceted 
pharmacist intervention to 
improve antihypertensive 
adherence: a cluster-randomized, 
controlled trial (HAPPy trial).  
Cluster 
Randomized 
control Trial 
Level II  
395 non- 
compliant 
hypertensive 
patients 
The intervention 
group had a 
significant reduction 
in mean SBP (10·0 
mmHg vs. 4·6 
mmHg; P = 0·05). 
Adherence also 
increased at 6 months 
by 22·6% (95% CI 
5·1-40·0%) higher in 
the intervention 
group (61·8% vs. 
39·2%, P = 0·007). 
Analysis- CI 
Interventions in form of 
medication education by 
pharmacist led to 
reduction in BP and 
increase in adherence to 
antihypertensive 
medication  
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Life Style Modification 
First Author Year 
Title/Purpose 
Research design 
Evidence level 
Sample 
Setting 
Results 
Analysis uses 
Limitation and or 
Usefulness 
Golshahi (2015). Effect of 
self-care education on 
lifestyle modification, 
medication adherence and 
blood pressure in 
hypertensive adults:  
 
 
 
 
 
Randomized 
controlled clinical 
trial. 
Level II 
The180 
patients with 
HBP   
assigned to 
four equal 
groups of A, 
B, C, and D. 
Group(intervention)
had a significant 
reduction in 
SBP/DBP (P = 
0.004), compared to 
group B (P = 0.001) 
and group C (P = 
0.02)  
Analysis- paired t-
test, ANOVA and CI  
Education lead to increase 
in consumption of more 
fruits and vegetable and 
better compliance to diet 
and life style modification 
Friedberg (2015), 
Effectiveness of a tailored 
behavioral intervention to 
improve hypertension 
control: primary outcomes 
of a randomized controlled 
trial Hypertension.  
 
Randomized 
controlled trial 
Level II 
705 Veterans 
with 
hypertension 
in out-patient 
settings 
6-month mean SBP 
for those in SMI 
(intervention) 
compared to 
UC(control ) (131.2 
versus 134.7; 
P=0.009) 
Analysis-CI 
Tailored behavioral 
intervention lead to 
adherence and reduction in 
BP 
Ogedegbe (2012). A 
randomized controlled trial 
of positive-affect 
intervention and 
medication adherence in 
hypertensive African 
Americans.  
A Randomized 
Control Trial 
Level II 
256 African 
American 
with 
hypertension 
PA group had a 
higher medication 
adherence at 12 
months than PE 
group (42% vs 36%, 
respectively; P 
=.049).  
Analysis-CI 
Personal affect motivation 
in combination with 
education improved 
adherence to medication 
more significantly than any 
of the interventions only 
Bosworth (2009). Two self-
management interventions 
to improve hypertension 
control: a randomized trial.  
Randomized 
control trial 
Level II 
636  adults 
with 
diagnosed 
primary 
hypertension  
in out-patient 
setting were 
enrolled in 
the study but 
475 
BP control relative 
to the usual care 
group were 4.3% 
(95% CI, -4.5% to 
12.9%) in the 
behavioral 
intervention group, 
7.6% (CI, -1.9% to 
17.0%) in the home 
BP monitoring 
Telephone intervention 
administered by nurses 
directed at hypertension-
related behaviors was able 
improved adherence to 
hypertension care  
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Culturally Tailored Health Education 
 
Multidimensional Interventions  
completed 
the study 
group, and 11.0% 
(CI, 1.9%, 19.8%) in 
the combined 
intervention group. 
Relative to usual 
care 
Analysis- CI 
First Author Year 
Title/Purpose 
Research design 
Evidence level 
Sample 
Setting 
Results 
Analysis uses 
Limitation and or 
Usefulness 
Beune (2014). Culturally 
adapted hypertension 
education (CAHE) to 
improve blood pressure 
control and treatment 
adherence in patients of 
African origin with 
uncontrolled hypertension: 
cluster-randomized trial.  
Cluster 
Randomized Trial 
Level II 
136 
hypertensiv
e patients 
from 
African 
origin, study 
completed 
in an 
outpatient 
setting 
Dissimilarities in 
SBP and DBP 
reduction were -1.69 
mmHg (95% CI: -
6.01 to 2.62, 
P=0.44) and -3.01 
mmHg (-5.73 to -
0.30, P=0.03) in 
favor of the 
intervention group. 
Analysis- CI 
Intervention in form  
of education,  
improved adherence 
 to antihypertensive  
therapy 
Meinema (2015),  
Determinants of Adherence 
to Treatment in 
Hypertensive Patients of 
African Descent and the 
Role of Culturally 
Appropriate  
Cohort study level 
IV 
The 
researchers 
evaluated 
data of 139 
patients who 
participated 
in the 
CAHE trial 
Culturally 
Appropriate Health 
Education (CAHE) 
was instrumental in 
patients’ adherence 
as it increased 
patients’ knowledge 
to chronicity of 
hypertension 
Adherence to  
antihypertensive regimen 
 was greatly influenced  
by medication  
self-efficacy and  
Social support. 
First Author Year 
Title/Purpose 
Research design 
Evidence level 
Sample 
Setting 
Results 
Analysis uses 
Limitation and or 
Usefulness 
Pouchain (2013). Effects of 
a multifaceted intervention 
on cardiovascular risk 
factors in high-risk 
hypertensive patients: the 
ESCAPE trial, a pragmatic 
cluster randomized trial in 
general practice.  
Cluster 
Randomized Trial 
Level II 
257 General 
practitioners 
and 1832 
hypertensiv
e patients in 
out-patient 
settings 
The was a 
significant increase 
in number of 
patients in the 
intervention group 
who attained their 
target blood pressure  
compared to those in 
the control group: 
OR (odds-ratio) 
1.89, (95% 
Education led to improved 
adherence and better BP 
control 
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confidence interval 
(CI) 1.09 to 3.27, P 
= 0.02). Analysis- 
odds ratio and CI 
Pladevall (2010). A Multi-
Center cluster-randomized 
trial of A Multi-factorial 
1ntervention to improve 
antihypertensive 
medication adherence and 
blood pressure control 
among patients at high 
cardiovascular risk (The 
COM99 study).  
Cluster 
randomized 
control trial 
Level II 
877 
Provides 
and patients 
with 
hypertensio
n. Study 
conducted 
in an out-
patient 
setting. 
The intervention 
patients had 
decrease in  SBP 
(odds ratio 0.62; 
95% confidence 
interval CI 0.50–
0.78) and were more 
likely to be adherent 
(OR 1.91; 95% CI 
1.19–3.05) when 
compared with 
control group  
Analysis- odds ratio 
and CI 
Multifactorial interventions 
has the prospect of 
improving adherence to 
hypertensive regimen 
Cheema (2014). The 
impact of interventions by 
pharmacists in community 
pharmacies on control of 
hypertension: a systematic 
review and meta-analysis 
of randomized controlled 
trials.  
Systematic Review 
Level II 
The 
researchers 
retrieved 
and 
reviewed 
340 articles  
publications 
up unto 
November 
2013 of 
which 16 
were 
randomized 
trials which 
included 
intervention
s that were 
pharmacist 
led 
The pharmacist led 
interventions group 
showed significant 
reductions in SBP in 
11 studies (2240 
patients); −6.1 
mmHg (95% 
confidence interval, 
−3.8 to −8.4 
mmHg); P < 
0.00001] and DBP 
in 11 studies (2246 
patients); −2.5 
mmHg (95% 
confidence interval, 
−1.5 to −3.4 
mmHg); P < 
0.00001]. 
Analysis-CI 
The pharmacist led 
interventions showed 
significant reductions in 
SBP 
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Appendix B 
The SIMPLE Method 
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Appendix C 
Cost for Project 
Item Cost 
Supplies and materials  $50.00 
Printing and Copying $300.00 
Dissemination  $100.00 
Total Cost  $450.00 
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Appendix D 
Logic Model 
 
Inputs 
 Intervention(s)                        Outputs  Outcomes -- Impact 
 Activities Participation  Short Medium Long 
Evidence, sub-topics 
•Education and support 
•Lifestyle Modification 
•Culturally Tailored 
Education 
•Multidimensional 
Intervention 
•Evidence Based Tool 
SIMPLE 
 
Major Facilitators or 
Contributors 
 
•Professional knowledge 
•Research findings that 
support project 
•Fostering the belief that 
project improves patient 
care 
•Building teamwork and 
collaboration 
 
Major Barriers or 
Challenges 
•Patients’ unwillingness 
to participate in the EBP 
•In adequate time to 
conduct education in 
outpatient setting 
•Inadequate knowledge 
of operational guideline 
of clinical site 
•Small participant 
number 
 EBP intervention 
supported by the 
evidence  
Education and 
support 
•Lifestyle 
Modification 
•Culturally 
Tailored 
Education 
•Multidimensional 
Intervention 
•Evidence Based 
Tool SIMPLE 
Major steps of 
the intervention   
Step 1 
Patient 
identification and 
Chart review 
Recruitment of 
participants’ 
education Obtain 
consent 
Step 2 Obtain 
baseline BP for 
study Obtain 
baseline 
Adherence score 
Step 3 Administer 
10 minutes 
structured 
education Using 
SIMPLE method 
Step 4 (3 months 
follow up) 
Measure BP 
Measure 
adherence 
Continue 
education Answer 
question 
Step 5 (6 months 
follow up)  
Measure BP  
Measure 
adherence 
Educate Answer 
questions 
The participants 
(subjects)   
Adults with 
hypertension who 
are  non-adherent to 
therapy and have 
BP consistently 
outside the target 
range per JNC 8 
guideline 
 
 
Site 
Rural health clinic, 
Missouri 
 
 
Time Frame  
September 2016 to 
March  2017(6 
months) 
 
 
Consent Needed or 
other 
Will be determined 
by UMKC IRB 
 
 
Person(s) 
collecting data 
 
Student  
Others directly 
involved   
Preceptor 
 (Completed as 
student)  
 
Outcome(s) to be 
measured with 
valid & reliable 
tool(s)  
 
•Adherence to 
therapy using Hill 
Bone Compliance 
Scale educational 
intervention 
•BP readings pre 
and post 
intervention 
 
 
 
 
 
Statistical analysis 
to be used  
 
Paired T-test 
(after student 
DNP)  
 
Outcomes to 
be measured  
 
 
 
Blood pressure 
 
 
 
 
 
 
 
 
 
(after 
student 
DNP) 
 
Outcomes 
that are 
potentials  
 
Knowledge 
of disease 
manageme
nt and 
importance 
of 
adherence 
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Appendix E 
Recruitment Script 
Excuse me, sir/ madam    
My name is Priscilla Agali  
I am a graduate student at school of Nursing University of Missouri Kansas City and for my 
doctorate project, I am working on a quality improvement project, on improving adherence to 
high blood pressure therapy. You received information about this project in the packet the nurse 
gave you during check in.  
I am approaching you because we are looking for adults who have uncontrolled high blood 
pressure. This study is totally separate from the care you are receiving here at clinic and whether 
or not you decide to participate it will not affect your care. I’m here to follow up to see if you are 
interested in hearing more about this project and if you would like to participate 
Should you decide to participate, you will be required to fill out a medication adherence form, 
and based on your responses, you will be provided education on how best to improve adherence 
to your provider prescribed therapy. You blood pressure will be checked before and after the 
education. 
 
 
 
 
 
 
 
 
 
 
     IMPROVING ADHERENCE TO ANTIHYPERTENSIVE REGIMEN                                 47 
 
Appendix F 
Intervention flow Diagram 
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Appendix G 
Project Timeline Flow Graphic 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
ACTION TIME 
Problem identification, linking 
problem with interventions and 
outcome 
PICOT formulation 
Completed 
Identify type and source of 
evidence. Conduct search 
Completed 
Synthesis of evidence Completed 
Define proposed change 
Identify needed resources and cost 
Design implementation plan 
Completed 
Implement project 
 Monitor process 
Completed 
Collect data 
Analyze data 
Communicate results to 
stakeholders 
Integrate into standard of practice 
Disseminate result of project 
Completed  
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Appendix H 
Change Model 
 
 
 
 
 
 
 
 
 
Stage 1: Unaware of recommended BP 
target and the need to adhere to 
provider recommended  BP  and 
treatment regimen. 
Check adherence level using a valid tool, 
Explore  and address barriers. Review BP 
medications and side effects. Provide 
education. Monitor BP
Stage 2: Aware but does not see need for 
adherence or following recommendations. 
Provide education on disease condition and 
consequences of nonadherence. Explore and 
address barriers
Stage 3: Aware but still 
contemplating to take 
action. 
Explore barriers and 
continue to provide 
education.
Stage 4: Decided 
not act. Continue to 
explore and 
address barriers. 
Monitor BP 
Stage 5: Planning to change. Continue to 
explore and address barriers. Continue to 
provide education
Stage 6: Has started making change 
(taking medication as prescribed and 
lifestyle modification). Continue to 
provide education and positive 
reinforcement. Monitor BP at home 
and during visit
Stage 7: Continues to make change and 
adheres to provider's recommended 
regimen. Continue to monitor BP and offer 
reinforcement during visit
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Appendix I 
Measurement Tool 
 
Lambert et al. (2006) 
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Appendix J 
Data Collection Template 
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Appendix K 
Definition of Terms 
Adherence: degree to which a patient’s behavior (taking medications, following a recommended 
diet, modifying lifestyle) parallels with provider’s prescription 
Hypertension: High blood pressure is a common disease in which blood flows through blood 
vessels (arteries) at higher than normal pressures 
Self-efficacy: ability of an individual to efficiently perform a behavior to yield the anticipated 
health outcome 
Quasi experimental design: a nonrandomized experimental study undertaken when it is not 
logistically possible or ethical to conduct a randomized controlled trial 
Validity: accuracy of an assessment, whether an instrument measures what it is supposed to 
measure 
Benchmark: any standard or reference by which others can be measured or judged 
Paired T-test: statistical analysis used to compare two population means 
Dissemination: to spread throughout 
Institutional Review Board: exist to protect the welfare and safety of research participants and to 
evaluate the balance of risks and benefits of a study within the context of a protocol while 
retaining the scientific relevance 
Autonomy: freedom of choice 
DE identified data: unique patient identifiable data have been removed (patients name, address, 
medical record number, age etc.) 
Wilcoxon signed rank test: non parametric test used to compare related sample 
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Appendix L 
Statistics Analysis Data Template 
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Appendix M 
IRB Approval Letter 
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Appendix N 
Result Table 
Paired Samples Test 
 
Paired Differences 
t 
d
f 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 1 Preintervention_
SBP - 
Postintervention_
SBP_3months 
2.50000 13.20227 5.38981 -11.35494 16.35494 .464 5 .662 
Pair 2 Preintervention_
SBP - 
Postintervention_
SBP_6months 
5.66667 10.91177 4.45471 -5.78453 17.11786 1.272 5 .259 
Pair 3 Preintervention_
DBP - 
Postintervention_
DBP_3months 
6.16667 9.60035 3.91933 -3.90828 16.24161 1.573 5 .176 
Pair 4 Preintervention_
DBP - 
Postintervention_
DBP_6months 
7.16667 7.93515 3.23951 -1.16077 15.49410 2.212 5 .078 
 
 
Paired Samples Statistics 
 Mean N Std. Deviation Std. Error Mean 
Pair 1 Preintervention_SBP 160.8333 6 8.90880 3.63700 
Postintervention_SBP_3months 158.3333 6 15.93319 6.50470 
Pair 2 Preintervention_SBP 160.8333 6 8.90880 3.63700 
Postintervention_SBP_6months 155.1667 6 15.27634 6.23654 
Pair 3 Preintervention_DBP 91.8333 6 6.85322 2.79782 
Postintervention_DBP_3months 85.6667 6 9.43751 3.85285 
Pair 4 Preintervention_DBP 91.8333 6 6.85322 2.79782 
Postintervention_DBP_6months 84.6667 6 8.98146 3.66667 
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Appendix O 
Result Table (Wilcoxon Signed Ranked Test) 
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Appendix P 
Graphic Representation of Result 
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Appendix Q 
Graphic Representation of Results 
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Appendix R 
UMKC Approval Letter 
 
